Abdulaziz Salah Ajab Alharbi
Biographic Data
| ID | 6954651 |
|---|---|
| NAME | Abdulaziz Salah Ajab Alharbi |
| GIVEN NAMES | Abdulaziz Salah Ajab |
| FAMILY NAME | Alharbi |
| SIGNATURE | ALHARBI A S A |
| AFFILIATIONS | Ministry of Health |
| ORCID | 0009-0007-4814-9452 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Comprehensive Review of Healthcare Disparities, Accessibility, and Quality Improvement Strategies
Since healthcare disparities have become one of the most significant issues globally, the availability and quality of healthcare are highly affected. These variations depend on many factors, such as socioeconomic level, race, region, and healthcare system organization. Though much has been done to overcome these disparities, both access to care and quality of care worsened among marginalized groups, consequently resulting in poorer health among t…
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Current strategies for improvements in the treatment of Alzheimer's disease
There have been many promising developments in recent years. Several new targets have been iden fied and new drugs developed, or exis ng drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cogni ve func on in animal models and in humans but then produced no significant benefit in AD pa ents in phase 3 trials. Several strategies …
Pharmacovigilance in clinical nursing
Background: The science of tracking and averting adverse drug reactions (ADRs), or pharmacovigilance, is essential to maintaining patient safety. Because they work closely with patients, nurses are frequently the first to notice adverse drug reactions (ADRs), and pharmacists offer their knowledge of drug interactions, dosage, and medication safety. Improving pharmacovigilance procedures requires these two professions to work together effectively.…
No prominent works on this page.
Pharmacovigilance in clinical nursing
Background: The science of tracking and averting adverse drug reactions (ADRs), or pharmacovigilance, is essential to maintaining patient safety. Because they work closely with patients, nurses are frequently the first to notice adverse drug reactions (ADRs), and pharmacists offer their knowledge of drug interactions, dosage, and medication safety. Improving pharmacovigilance procedures requires these two professions to work together effectively.…
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Comprehensive Review of Healthcare Disparities, Accessibility, and Quality Improvement Strategies
Since healthcare disparities have become one of the most significant issues globally, the availability and quality of healthcare are highly affected. These variations depend on many factors, such as socioeconomic level, race, region, and healthcare system organization. Though much has been done to overcome these disparities, both access to care and quality of care worsened among marginalized groups, consequently resulting in poorer health among t…
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Current strategies for improvements in the treatment of Alzheimer's disease
There have been many promising developments in recent years. Several new targets have been iden fied and new drugs developed, or exis ng drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cogni ve func on in animal models and in humans but then produced no significant benefit in AD pa ents in phase 3 trials. Several strategies …
Medicine (5 works) · Disease (3 works) · Engineering (3 works) · Health, Environment, Cognitive Aging (3 works) · Psychology (3 works) · Current (fluid (2 works) · Dementia and Cognitive Impairment Research (2 works) · Electrical engineering (2 works) · Health care (2 works) · Intensive care medicine (2 works)